| OFVIX | RMEBX | OFVIX / RMEBX | |
| Total Expense Ratio | 0.54 | 1.07 | 50% |
| Annual Report Gross Expense Ratio | 0.54 | 1.07 | 50% |
| Fund Existence | 10 years | 11 years | - |
| Gain YTD | 13.704 | 15.326 | 89% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000 | 250 | 4,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 272M | 112B | 0% |
| Annual Yield % from dividends | 1.78 | 1.03 | 173% |
| Returns for 1 year | -6.43 | 6.12 | -105% |
| Returns for 3 years | 28.42 | 27.12 | 105% |
| Returns for 5 years | 65.92 | 50.92 | 129% |
| Returns for 10 years | N/A | 88.58 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RTRRX | 8.13 | 0.10 | +1.25% |
| Royce Small-Cap Total Return R | |||
| WOOPX | 17.88 | 0.21 | +1.19% |
| JPMorgan SMID Cap Equity I | |||
| ALVRX | 11.50 | 0.09 | +0.79% |
| American Century Focused Lg Cap Val R | |||
| VFPIX | 18.31 | 0.09 | +0.49% |
| Private Capital Management Value I | |||
| MRIBX | 26.09 | 0.08 | +0.31% |
| MFS Research International B | |||